Screener
Gyre Therapeutics, Inc. GYRE Equity Gain Loss Of Unconsolidated Affiliates
Equity Gain Loss Of Unconsolidated Affiliates at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept gyre:EquityGainLossOfUnconsolidatedAffiliates.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s equity gain loss of unconsolidated affiliates?
- Gyre Therapeutics, Inc. (GYRE) reported equity gain loss of unconsolidated affiliates of -$22K in Q2 2026.
- How has Gyre Therapeutics, Inc.'s equity gain loss of unconsolidated affiliates changed year-over-year?
- Gyre Therapeutics, Inc.'s equity gain loss of unconsolidated affiliates decreased by 15.8% year-over-year, from -$19K to -$22K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s equity gain loss of unconsolidated affiliates?
- Over 2 years (2022 to 2025), Gyre Therapeutics, Inc.'s equity gain loss of unconsolidated affiliates has grown at a -44.6% compound annual growth rate (CAGR), from -$251K to -$77K.
- What does equity gain loss of unconsolidated affiliates mean?
- Equity Gain Loss Of Unconsolidated Affiliates as reported by Gyre Therapeutics, Inc. Common Stock.
Ask your AI about Gyre Therapeutics, Inc.'s equity gain loss of unconsolidated affiliates.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude